Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptor superfamily ligand-activated transcription factors that include the following three subtypes: PPAR, PPAR, and PPAR/. Higher organisms' cellular differentiation, development, metabolism (carbohydrate, lipid, and protein), as well as tumorigenesis, are all crucially regulated by PPARs. All PPARs bind to particular regions of the target genes' DNA through heterodimerization with the retinoid X receptor (RXR). Triglyceride levels are reduced and energy homeostasis is regulated when PPAR- is activated. PPAR- activation improves the metabolism of glucose, whereas PPAR-/ activation improves the metabolism of fatty acids.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V85378 | BAY-5094 | 2891706-78-6 | ||
V85379 | BAY-5516 | 2891706-79-7 | ||
V85720 | BAY-9683 | 2891706-83-3 | ||
V51330 | Bezafibrate-d6 | 1219802-74-0 | Bezafibrate-d6 is the deuterium labeled Bezafibrate. | |
V3800 | BMS-711939 | 1000998-62-8 | BMS-711939, an analog of BMS-687453, is a novel potent and selective peroxisome proliferator activated receptor (PPAR) alpha agonist, with an EC50 and IC50 of 4 nM for human PPARα and >1000-fold selectivity vs human PPARγ (EC50 of 4.5 μM) and PPARδ (EC50 > 100 μM) in PPAR-GAL4 transactivation assays. | |
V51348 | Bocidelpar (ASP-0367; MA-0211) | 2095128-20-2 | Bocidelpar is a peroxisome proliferator-activated receptor delta (PPAR-δ) modulator. | |
V51347 | Caulophyllogenin | 52936-64-8 | Caulophyllogenin is a novel and potent triterpene saponin extracted from M. polimorpha. | |
V51340 | CAY-10410 | 596104-94-8 | CAY10410 (11-Oxo-prosta-5Z), a 15d-PGJ2 analog, is a novel agonist of PPARγ. | |
V83405 | CAY10506 | 292615-75-9 | ||
V83362 | CAY10514 | 868526-38-9 | ||
V4093 | Choline Fenofibrate | 856676-23-8 | Choline fenofibrate (formerly also known as ABT-335 or choline salt of fenofibric acid) is a novel, synthetic phenoxy-isobutyric acid derivate with antihyperlipidemic activity that acts as anPPARαagonist. | |
V54369 | Ciprofibrate impurity A | 1474058-89-3 | Ciprofibrate impurity A is an impurity in Ciprofibrate. | |
V18511 | Clofibrate | 637-07-0 | Clofibrate (Atromid-S)is a novel and potent lipid-lowering agent acting as anagonist of PPAR with EC50s of 50 μM, ∼500 μM for murine PPARα and PPARγ, and 55 μM, ∼500 μM for human PPARα and PPARγ, respectively. | |
V51331 | Clofibrate-d4 | 1189654-03-2 | Clofibrate-d4, deuterium labeled Clofibrate. | |
V51349 | Clofibric acid-d4 (Chlorofibrinic acid-d4) | 184991-14-7 | Clofibric acid-d4 (Chlorofibrinic acid-d4), deuterium labeled Clofibric acid. | |
V52604 | Clofibric acid-d4 (Chlorofibric acid-d4) | 1184991-14-7 | Clofibric acid-d4 is the deuterated form of Clofibric acid. | |
V54370 | CRX000227 | 686769-92-6 | CRX000227 is a PPAR modulator. | |
V2124 | Daidzein | 486-66-8 | Daidzein is a naturally occuring isoflavone phytoestrogen isolated from Leguminosae, used as a component of foods and dietary supplements. | |
V51341 | Daidzein-d4 | 1219803-57-2 | Daidzein-d4 is the deuterium labelled form of Daidzein. | |
V51339 | DS-6930 | 1242328-82-0 | DS-6930 is a novel agonist of PPARγ, with an EC50 of 41 nM. DS-6930 has the potential to significantly lower plasma glucose (PG) while having fewer negative effects related to PPARγ than Rosiglitazone. |